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Abstract
The protein ataxin-3 consists of an N-terminal globular Josephin domain (JD) and an unstructured C-terminal region
containing a stretch of consecutive glutamines that triggers the neurodegenerative disorder spinocerebellar ataxia type 3,
when it is expanded beyond a critical threshold. The disease results from misfolding and aggregation, although the
pathway and structure of the aggregation intermediates are not fully understood. In order to provide insight into the
mechanism of the process, we monitored the aggregation of a normal (AT3Q24) ataxin-3, an expanded (AT3Q55) ataxin-3,
and the JD in isolation. We observed that all of them aggregated, although the latter did so at a much slower rate.
Furthermore, the expanded AT3Q55 displayed a substantially different behavior with respect to the two other variants in
that at the latest stages of the process it was the only one that did the following: i) lost its reactivity towards an anti-
oligomer antibody, ii) generated SDS-insoluble aggregates, iii) gave rise to bundles of elongated fibrils, and iv) displayed
two additional bands at 1604 and 1656 cm
21 in FTIR spectroscopy. Although these were previously observed in other
aggregated polyglutamine proteins, no one has assigned them unambiguously, yet. By H/D exchange experiments we show
for the first time that they can be ascribed to glutamine side-chain hydrogen bonding, which is therefore the hallmark of
irreversibly SDS-insoluble aggregated protein. FTIR spectra also showed that main-chain intermolecular hydrogen bonding
preceded that of glutamine side-chains, which suggests that the former favors the latter by reorganizing backbone
geometry.
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Introduction
Ataxin-3 (AT3) is a 42 kDa intracellular protein that is
responsible for the polyglutamine (polyQ) disease spinocerebellar
ataxia type 3, when the length of its polyQ tract exceeds about 50
consecutive residues [1–3]. It consists of the N-terminal Josephin
domain (JD), whose structure has recently been solved by NMR
[4] and of a disordered C-terminal domain, wherein the polyQ
stretch is close to the C-terminus [5]. The JD is structurally similar
to some members of the cysteine protease family, and also has the
catalytic triad found in these enzymes [4], sustaining ubiquitin
hydrolase activity in AT3 [6,7].
Plenty of work has been carried out in recent years to elucidate
the mechanisms underlying the aggregation of AT3 and other
polyQ-containing proteins, which has highlighted the complexity
of the process, showing in particular that the protein context and
the polyQ-flanking regions critically affect the mode and outcome
of aggregation [8,9]. As far as AT3 is concerned, it has been shown
that the JD also has an intrinsic amyloidogenic potential, which
results in the wild-type protein’s capability to aggregate, a feature
also shared by truncated variants, including the JD in isolation
[10,11]. This implies that the aggregation pathway consists of two
steps: the first, only requiring the JD, gives rise to SDS-soluble
protofibrils, whereas the second is solely accessible to variants
carrying expanded polyQs and results in the formation of mature,
SDS-insoluble fibrils [12,13]. Nevertheless, these variants display
the fastest aggregation kinetics, which suggests that the polyQ tract
also affects the mode of JD aggregation [14]. It is noteworthy that
other proteins, in particular ataxin-1 and huntingtin exon-1, also
have polyQ-flanking regions that participate in the process and
substantially affect the features of the resulting aggregates [15,16].
Interestingly, Robertson and coworkers recently showed that the
small heat-shock protein alphaB-crystallin retards or prevents
aggregation of both JD and AT3 by selectively interacting with an
extensive region of the JD [17]. This finding further highlights the
key role of the latter in the first step of the aggregation process.
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18789Based on x-ray diagrams of a short polyQ peptide (D2Q15K2)
and on theoretical considerations, Perutz and coworkers proposed
that amyloid fibers generated by expanded polyQs would consist
of at least two b-helical turns each containing 20 residues, and that
residues in successive turns would be linked by hydrogen bonds
between both main chain and side chain amides [18]. Although
Sikorski and Atkins suggested an alternative model wherein the
peptide adopts a hairpin conformation, they also surmise that the
glutamine residues are hydrogen bonded via both main- and side-
chain amides [19]. Nevertheless, experimental data available to
date do not adequately depict the changes taking place at the
molecular level at different stages of aggregation in both normal
and expanded polyQs. In particular, as far as the latter are
concerned, the molecular events that lead to the conversion of
reversibly aggregated oligomers into stably aggregated fibrils are
still largely obscure.
Taking advantage of several analytical methods, especially
FTIR spectroscopy, we provide here an in-depth analysis of such
changes in a normal and an expanded AT3 variant, as well as in
the JD in isolation. In particular, our results provide the first
experimental evidence that side-chain hydrogen bonding of
polyQs is responsible for irreversible aggregation and SDS-
insolubility of the expanded form.
Results
Different truncated, normal full length and expanded
AT3 variants undergo aggregation as detected by
Thioflavin T (ThT) fluorimetry
To achieve a deeper understanding of the structural changes
associated with AT3 fibrillogenesis, we investigated different forms
of AT3, i.e.: AT3/182D (truncated at the residue 182 and
consisting of the sole JD); AT3Q24 and AT3Q55 (full-length
normal and pathogenic, carrying 24 and 55 consecutive
glutamines, respectively).
By ThT fluorimetry, we first assessed the propensity of the
different variants to aggregate at 37uC over a time span of 68 h,
which showed that all of them were capable of doing so, although
at different rates (Fig. 1A). As a control, b-lactoglobulin did not
undergo any fluorescence increase under the same conditions (data
not shown). The AT3/182D variant also underwent aggregation
as expected [11], although at a much slower rate than the others.
The polyQ-carrying variants, AT3Q24 and AT3Q55, aggregated
much more rapidly than the truncated ones, AT3Q55 displaying a
somewhat higher rate than AT3Q24. In particular, they attained a
plateau at about 10 h and 30 h, respectively. No lag phase was
detectable for these two variants. This, however, might be due to
the high rate of the process.
Dot-blot assays show a different aggregation pattern of
AT3Q55 compared to the other variants
We also analyzed the aggregation products generated by the
different AT3 variants by assessing the appearance of oligomeric
forms in dot-blot assays performed at different incubation times.
To this end, we used an antibody that is capable of selectively
recognizing the earliest aggregation products but not mature fibrils
[20]. We thus observed that the AT3Q55 oligomers progressively
decreased from the beginning and disappeared completely at 30 h,
whereas the two other variants displayed an approximately
constant level of oligomers over the entire incubation time
(Fig. 1B). This is strongly suggestive of the unique capability of
the expanded form to evolve towards mature fibrils, as also
confirmed by FTIR spectroscopy, filter trap assays and AFM
(reported below). The reactivity detected at zero-time suggests that
oligomeric forms are present from the very beginning of the
incubation. It should be stressed, however, that the initial amount
of aggregated protein, quantified on the basis of FTIR bands at
1630–1624 and 1695 cm
21 as outlined below, was hardly
detectable in all AT3 variants.
The secondary structures of AT3 variants are identified by
FTIR spectroscopy
FTIR spectroscopy can very precisely discriminate between
closely related but different protein secondary structures for
instance, b-intermolecular versus b-intramolecular sheets [21],
which is relevant to the subject of the present work. We thus
monitored the time-dependent structural changes of the different
AT3 variants under investigation. However, we first assessed the
secondary structure content of freshly purified proteins. In Fig. 2A,
Figure 1. Progress of the aggregation of AT3 variants. (A) Aggregation was monitored by measuring changes in ThT fluorescence of proteins
incubated at 37uCa ta2 5mM concentration in PBS, pH 7.2, and in the presence of 20 mM ThT. Fluorescence was recorded using a plate reader with
values read every 30 min. Individual values are the mean of three independent determinations, with standard deviations never exceeding 5% of the
mean value. Fluorescence is relative to the highest value, achieved at a 60 h-incubation. (B) Time course of oligomeric AT3 form appearance, as
detected by dot blot. AT3 variants were incubated at 37uC in PBS, pH 7.2, for the times indicated. Samples were withdrawn, applied to an Immobilon
membrane, immunodecorated using anti-oligomer, conformation-specific antibodies (19) and revealed using ECL Western blotting reagent.
doi:10.1371/journal.pone.0018789.g001
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presented. This is mainly contributed by the C=O peptide bond
absorption whose peak position is sensitive to the protein’s
secondary structure [22–25]. In order to resolve this band into
its overlapping components, the second derivative analysis of the
spectrum [22] was performed. Two main components, appearing
as negative peaks, were detected at 1657 and 1635 cm
21. The
former can be assigned to a-helices and random coils; the latter,
along with a shoulder around 1690 cm
21, to native, intramolec-
ular b-sheets. In addition, two low-intensity components at about
1688 and 1678 cm
21 were found in the typical absorption region
of b-turns [22–25], in keeping with the secondary structure
components reported for the JD [4,11]. The second derivative
spectra of the two other AT3 variants were similar to each other
and displayed the same secondary structure components found in
the JD (Fig. 2B, 2C). They, however, exhibited a 1657 cm
21 band,
which was more pronounced than that around 1635 cm
21,
contrary to the JD (Fig. 2A). This indicates that the C-terminal
disordered domain must contribute to the absorption of the
1657 cm
21 component. Thus, we conclude that the secondary
structure of this stretch is mainly a-helical and/or disordered,
consistent with CD spectra and computational studies [11]. It is
also noteworthy that the glutamine side-chain infrared response,
which in the amide I region is expected in the ranges 1687–
1668 cm
21 and 1611–1586 cm
21 [26], was undetectable in the
freshly purified AT3Q55 spectrum, probably due to structural
heterogeneity of the polyQ stretch (Fig. 2B, 2C).
FTIR spectroscopy highlights major changes in the
secondary structure of AT3 variants upon incubation
under physiological conditions
Previous studies showed that AT3 undergoes aggregation under
physiological conditions, with resulting generation of amyloid-like
structures [13,14]. To assess the changes in secondary structure
associated with this process, we incubated the AT3 variants under
investigation at 37uC, and collected FTIR spectra at different
times (Fig. 3). JD second derivative spectra showed a slow decrease
in the 1657 cm
21 and 1635 cm
21 components, which are
contributed by a-helix/disordered and native b-sheet structures,
respectively. In addition, between 48 and 72 h of incubation, two
further low-intensity components appeared as shoulders around
1630 cm
21 and 1694 cm
21. These bands, which became better
resolved at 168 h (Fig. S1), occur in the absorption region of
intermolecular b-sheets, so they are diagnostic of aggregation
[21,27,28]. A similar behavior was observed in the case of
AT3Q24, with two major differences. First, the peak position of
the aggregation band at 1630 cm
21 in the case of the JD, occurred
instead around 1624 cm
21 (Fig. S1). This downshift points to
tighter aggregates in AT3Q24, probably resulting from stronger
hydrogen bonding and/or increased number of b-strands in the
intermolecular b-sheets ([29] and references therein). Second, the
aggregation of this variant was distinctly faster than that of the JD,
as apparent from the comparison of the aggregation bands of the
different proteins (shown in Fig. 3). This result fits well with the
kinetics monitored by ThT fluorescence (Fig. 1A), thus confirming
that the disordered C-terminal domain significantly enhances the
aggregation rate. Furthermore, these spectral data also show that
in the presence of this domain, the resulting aggregation products
are to some extent structurally different from those generated by
the JD alone.
The time-dependent spectral changes in the second derivative
spectra of the pathogenic AT3Q55, whilst sharing some features
with those of the other forms, also displayed unique traits. In
particular, the native b-sheet component at 1635 cm
21 underwent
a decrease in intensity like the other forms, whereas the a-helix/
disordered component at 1657 cm
21 first decreased until 30 h.
Thereafter it increased again, thus exceeding the zero-time
intensity (Fig. 3). The absorption spectrum of AT3Q55 displayed
a band at 1657 cm
21 whose intensity was lower in the aggregated
protein compared to the freshly prepared sample (Fig. S2). This
Figure 2. FTIR spectra of freshly purified AT3 variants. Absorption spectra (dotted line) and their second derivatives (continuous line) in the
amide I region of AT3 variants: JD (A), AT3Q24 (B), and AT3Q55 (C). Band assignment to the secondary structure components is indicated.
doi:10.1371/journal.pone.0018789.g002
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absorption and second derivative spectra can be accounted for if
one considers that peak intensities in the second derivative spectra
are inversely correlated with band widths [22], with resulting
intensification of narrow bands. The observed narrowing of the
1657 cm
21 component is suggestive of a highly ordered structure.
Furthermore, the aggregation bands around 1624 cm
21 and
1695 cm
21 started to increase from the earliest stages of the
incubation, reaching intensities higher than those of the other
variants (Fig. 3). This holds true in particular for the 1624 cm
21
band intensity that in AT3Q55 aggregates was twice as strong
after a 168-h incubation as that of the AT3Q24 aggregates (Fig.
S1). Most notably, we also observed an additional band at
1604 cm
21 (Fig. 3) that was also retained in the spectrum of
AT3Q55 mature aggregates (Fig. S1). Although it was already
found in protein and peptide aggregates containing polyQs
[16,30–32], it has not yet been unambiguously assigned.
H/D exchange experiments allow one to unambiguously
identify the IR spectral components contributed by
irreversibly aggregated, expanded polyQ stretches
The amide I and II second derivative spectrum of the AT3Q55
aggregates, collected by centrifugation of the protein solution after
168 h of incubation, is presented in Fig. 4.
In H2O, the amide I spectrum displayed four well resolved
bands at 1695 cm
21, 1657 cm
21, 1624 cm-1 and 1604 cm
21.
Whereas the 1695 cm
21 and 1624 cm
21 components can be
definitely assigned to the intermolecular b-sheet interaction of the
protein aggregates [21,27,28], the two other bands were assigned
by other authors to different vibrational modes. In particular,
bands at about 1658 cm
21 and 1604 cm
21 were found in the
spectrum of model polyQ peptides and both assigned to
intermolecular b-sheets [30]. Such bands were also observed in
the amyloid aggregate spectra of the cyclin-dependent kinase
subunit by Bader et al. [31], who suggested an assignment to
hydrogen-bonded glutamine side-chains instead. Thus, for a
conclusive assignment of these bands, we performed H/D
exchange experiments.
Indeed, several reports show that in both free and protein-
bound glutamines, the C=O stretching absorption of side chains
was found to downshift from 1687–1668 cm
21 in H2O to 1654–
1635 cm
21 in D2O, while the NH2 deformation mode of side
chains underwent a very large shift, from 1611–1586 cm
21 in
H2O to about 1163 cm
21 in D2O (for a review see ref. [26]).
These downshifts, which are considerably larger than those
expected for the protein backbone bands upon deuteration
[26,33], allowed us to discriminate between glutamine side-chain
IR response and that of protein backbone in aggregates. We
therefore incubated freshly prepared AT3Q55 at 37uCi nD 2O.
Under these conditions, deuterated aggregates were obtained, as
indicated by the downshifted IR band positions in the amide I
region (Fig. 4). Actually, in D2O, the two bands at 1695 cm
21 and
1624 cm
21 downshifted to 1685 cm
21 and 1613 cm
21, respec-
tively, as expected for intermolecular b-sheet backbone modes.
Most notably, the bands at 1657 cm
21 and 1604 cm
21 displayed
major downshifts, the former to 1637 cm
21, the latter actually
disappearing from the amide I and amide II regions and shifting
into the crowded absorption region around 1160 cm
21. These
results suggest that the 1657 cm
21 and 1604 cm
21 components
can be assigned to the C=O stretching and NH2 deformation
modes of the glutamine side chains, respectively, in AT3Q55
amyloid aggregates. To support this assignment, we performed an
additional H/D exchange experiment aimed at further investigat-
ing glutamine interactions in the AT3Q55 amyloid aggregates.
Aggregates obtained after incubation of the freshly purified protein
in H2O buffer at 37uC for 168 h were subsequently submitted to
three cycles of lyophilization and resuspension in D2O, as
described in Materials and Methods. After this drastic treatment,
the FTIR spectrum of AT3Q55 mature aggregates (Fig. 4) still
displayed the two components at 1657 and at 1604 cm
21, thus
showing that no H/D exchange with the solvent took place under
these conditions. This makes it possible to exclude the assignment
of the 1657 cm
21 band to unordered structures. This result is
indeed expected for glutamines involved in strong side chain-side
chain (and possibly side chain-backbone) hydrogen bonding.
The above experiments therefore provide conclusive evidence
supporting the previous proposed models [18,19], whereby
glutamine residues in irreversibly aggregated, expanded polyQ
stretches, are linked by hydrogen bonds between both main chain
Figure 3. Kinetics of aggregation of AT3 variants monitored by
FTIR spectroscopy. Second derivative spectra of AT3 variants were
taken at different times of incubation in PBS at 37uC. Arrows point to
increasing time.
doi:10.1371/journal.pone.0018789.g003
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of glutamine side chains in AT3Q55 amyloid aggregates occurs in
H2O at 1657 cm
21, which is outside the typical range of free
glutamine (1687–1668 cm
21). This downshift is further evidence
that glutamine side chains are involved in strong hydrogen
bonding.
AT3Q55 intermolecular backbone hydrogen bond
formation precedes that of glutamine side chains, the
latter resulting in irreversible aggregation
We also monitored the kinetics of appearance of the bands at
1624 cm
21 and 1604 cm
21 that are assigned to b-sheet
intermolecular interactions and glutamine side chain NH2
deformation mode, respectively. The time course shows that the
increase in the b-sheet intermolecular band started at the very
beginning of the incubation, reaching a plateau after 50–80 h
(Fig. 5). In contrast, the glutamine band appeared after 30 h and
leveled off in a time interval comparable to that of b-sheets.
Remarkably, the appearance of the glutamine band was paralleled
by that of SDS-insoluble aggregates, as detected by filter trap
assays (Fig. 5). This distinctive IR response could not be abolished
by SDS treatment (Fig. S3). It is well known that only expanded
AT3 variants undergo irreversible aggregation, whereas wild-type
forms do not go beyond the first reversible aggregation step [13].
Thus, our results also demonstrate that the rearrangement of
glutamine side chains and the resulting side-chain hydrogen
bonding observed in the expanded variant is the key event
resulting in the generation of irreversible aggregates.
AFM confirms that only the expanded AT3Q55 generates
fibrils
Tapping mode AFM was employed to investigate the
morphologies of the aggregates formed by JD, AT3Q24 and
AT3Q55 at fixed aggregation times. At all the times analyzed, the
JD formed globular particles with a mean height of 3.660.1 nm
that displayed a relatively low propensity to form clusters of
spheroidal aggregates even after 72 h from the start of the
aggregation experiment (Fig. S4). A more complex aggregation
behavior was shown by AT3Q24 that evolved from globular
particles with a mean height of 4.960.2 nm at t=0 to clusters of
particles at 24 h (Fig. S5A and B). After 72 h, most of the
aggregates still exhibited a non-fibrillar morphology, while only
Figure 4. Effect of H/D exchange on FTIR spectra of ATQ55 aggregates. Freshly purified AT3Q55 was incubated in H2O/PBS (spectrum 1) and
in D2O/PBS (spectrum 2) at 37uC for 168 h. The second derivative spectra of the pelletted aggregates are reported. Upon deuteration, the shift of the
cross b-sheet bands (continuous arrows) and the glutamine side chain bands (dotted arrows) are indicated. In a different H/D exchange experiment,
freshly purified AT3Q55 was incubated in H2O/PBS at 37uC for 168 h and the obtained mature aggregates were subsequently submitted to three
cycles of lyophilization and resuspension in D2O, as described in Materials and Methods. Then, the mature aggregates were resuspended in D2O and
their ATR/FTIR second derivative spectrum recorded (spectrum 3). No appreciable H/D exchange with solvent took places under these conditions,
except for the minor one of the 1695 cm
21 component.
doi:10.1371/journal.pone.0018789.g004
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observed (Fig. S5C).
At the start of aggregation the expanded variant AT3Q55 also
showed a distribution of globular particles of variable size (Fig. 6A),
with a mean height of 3.160.2 nm. A globular morphology was
also detected after 2 h (Fig. 6A, inset), but the mean particle height
was increased to 5.160.2 nm. After 24 h from the start of
aggregation, the globular oligomers were found to be assembled
into clusters (Fig. 6B), while at 48 h bundles of fibrils, almost
totally submerged by non fibrillar material, were observed (Fig. 6C
and Fig.S6). Sample treatment with SDS and centrifugation, as
detailed in Materials and Methods, were performed to recover the
insoluble fibrillar fraction (Fig.6C, inset). Bundles of fibrils became
the prevailing morphology observed after 72 h; treatment with
SDS allowed us to better reveal the ultrastructure of these bundles.
They turned out to be composed of fibrils about 4 nm high
intertwined together and further assembled into bundles between
20 and 60 nm high (Fig. 6D).
Discussion
This work was aimed at characterizing the structural features
emerging during the aggregation in both normal (Q24) and
expanded (Q55) AT3, as well as in the JD in isolation. We first
monitored the kinetics of the process by ThT fluorimetry, which
showed that all the variants investigated underwent aggregation,
that AT3/182D (consisting of the sole JD) aggregated much more
slowly than the two other forms, and that it displayed an evident
lag phase, in keeping with the previously proposed nucleation-
dependent mechanism [14]. This, of course, does not rule out that
the two full-length variants also undergo a lag phase, which might
be however undetectable due to the much higher aggregation rate.
It is worth mentioning, in any case, that these results confirm the
intrinsic amyloidogenic potential of the JD, as previously proposed
[10,11] but, at the same time, they highlight the effect of the C-
terminal disordered domain to substantially enhance the rate of
the process.
By dot-blot and filter trap assays we provided a further
characterization of the intrinsic properties of these aggregates. In
dot blots we used an antibody that is capable of selectively
recognizing oligomers but not mature fibrils [20]; in filter trap
assays an anti-AT3 antibody. Our results show that all three forms
were initially recognized by the anti-oligomer antibody, but AT3/
182D and AT3Q24 gave an approximately constant signal over
time unlike AT3Q55, whose signal progressively faded and
completely disappeared at a 30-h incubation (Fig. 1B). This was
paralleled by the appearance of the filter-trap signal by the same
expanded AT3 form after 30 h (Fig. 5), whereas in contrast, no
reactivity was displayed by the two other variants.
To further confirm these findings we also characterized the
morphology of the three AT3 variants by AFM, which actually
showed that AT3Q55 underwent progressive aggregation, gener-
ating oligomers (Fig. 6A), which formed clusters after 24 h (Fig. 6B)
and gave rise to bundles of tangled SDS-resistant fibrils at 48 and
72 h (Fig. 6C and D). Nevertheless, a closer inspection of the
images also suggests that, taken individually, fibrils are un-
branched. The morphology of these bundles of fibrils resembles
that reported for synthetic polyQ peptides [34]. As expected, the
normal full-length AT3Q24 only generated oligomers and short
protofibrils even at the latest times of incubation (Fig. S5), and the
JD generated a prevailing globular morphology (Fig. S4). These
are among the first AFM images taken of AT3 during aggregation.
Overall, these results provide a comprehensive framework of the
events taking place during aggregation of normal and expanded
AT3 that confirms the previously proposed two-step kinetics
[12,13]. Nevertheless, very little is known so far regarding the
structural changes accompanying the different stages of the
process. We thus addressed this issue by taking advantage of
FTIR spectroscopy. We collected second derivative spectra in the
amide I band region of the three forms, before and during the
incubation. Before the incubation they were fairly similar,
indicative of a-helical/disordered structures (1657 cm
21 band),
intramolecular b-sheets (1635 cm
21) and b-turns (1688 cm
21 and
1678 cm
21). The most notable difference was that the 1657 cm
21
band was more pronounced than the one around 1635 cm
21 in
the full-length AT3 forms compared to the JD. This implies that
the C-terminal disordered domain must contribute to the
absorption of the 1657 cm
21 component, and that it is mainly
a-helical and/or disordered, consistent with CD spectra and
computational studies [11].
During the incubation, JD and AT3Q24 spectra underwent
similar changes that point to a decrease in intramolecular b-sheet
and a-helical/disordered structures, and a concurrent increase in
intermolecular b-sheet, clearly representative of the aggregation
process. However, the full-length variant aggregated much faster
than the JD and, in addition, displayed a downshift of the b-
intermolecular band from 1630 cm
21 to 1624 cm
21, suggestive of
stronger interactions and/or increased number of b-strands. This
clearly shows that the C-terminal domain also affects stability and
structure of the aggregates, irrespective of whether it carries
normal or expanded polyQs.
Although the aforementioned results make a significant
contribution to the understanding of the mechanisms of AT3
fibrillogenesis, the key discovery of the present work is the
elucidation of a major, distinctive structural feature arising during
the aggregation of the expanded form but not of the normal one,
namely hydrogen bonds among glutamine side-chains. Actually,
by H/D exchange we could unambiguously assign the 1657 cm
21
and 1604 cm
21 bands to glutamines involved in strong side-chain-
side chain (and possibly side chain-backbone) hydrogen bonding in
the AT3Q55 mature amyloid aggregates. Therefore, based on our
Figure 5. Time course of AT3Q55 aggregation upon incubation
at 376C in PBS. Aggregation was monitored by detecting either the
appearance of SDS-insoluble aggregates by filter trap assays (upper
panel), or cross b-sheet (1625 cm
21) and glutamine side chain bands
(1604 cm
21) (lower panel). The band heights from the second
derivative spectra (normalized at the tyrosine peak to allow for possible
differences in protein content) are reported as percentage variations in
the time span 0–168 h. Standard deviations from three independent
experiments are indicated.
doi:10.1371/journal.pone.0018789.g005
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expanded AT3 variants. So they are associated with, and
responsible for irreversible aggregation and SDS-insolubility of
the expanded forms. As a matter of fact, the appearance of the
side-chain glutamine signal after about 50 h of incubation was
paralleled by the formation of irreversibly aggregated proteins and
bundles of SDS-resistant, mature fibrils, as shown in filter trap
assays and in AFM, respectively. Even more remarkably, the time
course of the appearance of main-chain and side-chain hydrogen
bonding showed that the former started from the very beginning of
incubation, whereas the latter became significant after 30 h (Fig.6).
So it is quite likely that the constraints generated at the level of the
main chain are a prerequisite for side-chain hydrogen bonding,
probably favoring the latter interaction entropically. Once either
interaction is formed, the protein would remain locked in an
irreversibly aggregated conformation.
Based on x-ray crystallography of a small glutamine peptide, i.e.
D2Q15K2, and on theoretical considerations, Perutz and cowork-
ers proposed that polyQs generate amyloid fibers consisting of at
least two b-helical turns each of 20 residues, and that residues in
successive turns would be linked by hydrogen bonds between both
main chain and side chain amides [18]. After inspecting the same
crystallographic data, Sikorski and Atkins [19] suggested an
alternative model, in which the peptide adopts a hairpin
conformation but still displays a similar pattern of hydrogen
bonding.
Whatever the real structure of polyQ amyloids may be, these
results highlight glutamine side-chain hydrogen bonding as a key
structural feature for the generation of irreversible aggregates. At
first glance, however, it is surprising that the models described rely
upon experimental data obtained from a short polyQ peptide,
whereas our observations unambiguously show that only expanded
polyQ stretches can give rise to such aggregates and the related
pattern of hydrogen bonding. These apparently conflicting results
can be reconciled if one assumes that the protein context, in
particular the flanking regions, play a crucial role in determining
the aggregation pathway. In other words, even a short polyQ
stretch in isolation would be subject to irreversible aggregation,
whereas a much longer polyQ stretch would be required to
achieve aggregation of normal sized proteins. Actually, the typical
threshold for aggregation and onset of polyQ diseases is around 40
consecutive glutamines [35]. Interestingly, a recent paper shows
that, in keeping with this hypothesis, synthetic polyQ peptides of
non-pathological length (e.g., KKQ32KK) are much more prone
to aggregation than a huntingtin exon 1 variant containing a Q53
stretch [36]. These results, along with ours and those of Perutz and
Sikorski, substantiate the idea that glutamine side-chain hydrogen
bonding is a common feature of all natural, irreversibly aggregated
polyQ proteins.
As a final remark, it is worth mentioning that the FTIR
spectroscopic methods adopted in the present work also allow one
to monitor the progress of aggregation in vivo by detecting the
Figure 6. Tapping mode AFM images (height data) of the expanded variant AT3Q55 incubated at 376C. The protein was incubated for:
(A) 0 h (inset 2 h); (B) 24 h; (C) 48 h; (D) 72 h. The samples imaged in the inset of (C) and in (D) were treated with SDS (see Materials and Methods) to
remove non fibrillar material. Scan size: (A, B, D) 2 mm; (C) 5 mm; insets 1 mm. Z range: (A) 10 nm, inset 20 nm; (B) 30 nm; (C) 700 nm, inset 180 nm;
(D) 150 nm.
doi:10.1371/journal.pone.0018789.g006
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[38] and Caenorhabditis elegans [39,40]. This provides an invaluable
tool to correlate the emerging toxic effects in such organisms with
the subtle structural features of the different aggregation products
arising during the process.
Materials and Methods
Cloning, expression and purification of AT3 variants
Plasmid encoding the fragment 1–182 (that consists of the sole
JD) was obtained by inserting, into the wild-type human AT3
(AT3Q24-isoform 2UIMs) gene cloned in pGEX-6P-1 (GE
Healthcare LifeSciences, Little Chalfont, England), two stop
codons downstream of the triplet encoding the residue 182. The
truncated form (AT3/182D) was expressed in the E. coli strain
BL21-CodonPlus(DE3)-RIL (E. coli BF
2 ompT hsdS (rB
2 mB
2) dcm
+
Tet
r gall(DE3) endA Hte [argU ileY leuW Cam
r] (Stratagene, La
Jolla, CA, USA) in fusion with GST, with a Prescission Protease
cleavage site in between, and purified as previously described [41].
The cDNA-encoding human wild type AT3Q24 was removed by
BamHI-SmaI digestion from pGEX-6P-1 and subcloned in the
pQE-30 vector (Qiagen Hamburg GmbH, Hamburg, Germany).
The expanded form (AT3Q55) was chemically synthesized by
Eurofins MWG Operon (Ebersberg, Germany) and cloned in the
pQE30 vector. The two variants were expressed in SG13009 (E.
coli K12 Nal
s, Str
S, Rif
S, Thi
2, Lac
2, Ara
+, Gal
+, Mtl
2
, F
2,
RecA
+, Uvr
+, Lon
+; Qiagen Hamburg GmbH, Hamburg,
Germany) as His-tagged proteins. The proteins were purified
following the procedure reported by Chow et al. [42], except that
only AT3Q55 was subjected to the last purification step, consisting
of a gel filtration on a HiPrep 16/60 Sephacryl S-100 High
Resolution column (GE Healthcare, Life Sciences, Little Chalfont,
England), pre-equilibrated with PBS-G (20 mM potassium
phosphate, pH 7.2, 150 mM NaCl, 1 mM 2-mercaptoethanol
and 10% glycerol). Elution was performed at a flow rate of 0.5 ml/
min in the same buffer. Fractions (1 ml) were collected and
analyzed by SDS-PAGE electrophoresis. Fractions containing
pure AT3Q55 were concentrated in an Amicon Ultra 30 K
microconcentrator (Millipore, Bedford, MA, USA) and stored at
220uC. Before use, AT-3 variants were centrifuged at 150006g
for 15 min at 4uC to eliminate aggregates.
Thioflavin T (ThT) assays
AT3 variants were incubated at a 25 mM concentration in PBS
(25 mM potassium phosphate, pH 7.2, 0.15 M NaCl) at 37uC
with 20 mM ThT, in clear-bottomed black Isoplate-96F/50B
plates (Perkin Elmer, MA, USA) and read in a VICTOR TM X3
Multilabel Plate Reader (Perkin Elmer, MA, USA). Excitation and
emission wavelengths were 445 nm and 535 nm, respectively.
Readings were carried out from the bottom of the plates with no
shaking and recorded every 30 min. Plates were sealed to prevent
evaporation. Storage buffer was replaced by PBS immediately
prior to each experiment using PD10 desalting columns (GE
Healthcare LifeSciences, Little Chalfont, England). Protein
content was determined using Comassie brilliant blue G-250 from
Pierce (Pierce Biotechnology, Rockford, IL) and bovine serum
albumin as a standard protein.
Dot Blot and filter trap assays
Dot blot and filter trap assays were performed on AT3 samples
incubated in PBS buffer at 37uC and a 1 mg/ml concentration
without shaking. Dot blotting was performed by applying protein
aliquots (13 mg) to a nitrocellulose membrane mounted on a
manifold. Samples were vacuum-filtered and washed with 200 ml
of PBS. Membranes were incubated in blocking solution (5% skim
milk in PBS) for 60 min at room temperature and then probed for
60 min at room temperature with anti-amyloid oligomer (Abeta)
antibody (Millipore, Bedford, MA, USA; Kayed et al., 2003) at
1:5000 dilution in blocking solution. After incubation in primary
antibody, membranes were washed thrice in 0.3% Tween in PBS
for 10 min each time, and subsequently incubated for 60 min at
25uC in secondary antibody (horseradish peroxidase-goat anti-
rabbit antibodies) at 1:5000 dilution. Immunoreactive bands were
revealed using ECL Western blotting reagent (GE Healthcare
LifeSciences, Little Chalfont, England). For the filter trap assay,
AT3 aliquots (10 ml-samples, 1 mg/ml protein concentration)
were mixed with 500 ml of SDS buffer (50 mM Tris-HCl, pH 8.0,
5% SDS, 10 mM DTT, 100 mM NaCl, 1 mM EDTA). After a
10 min incubation at 100uC, the resulting samples were applied to
a cellulose acetate membrane (0.2 mm pore size) mounted on a
manifold, vacuum-filtered, washed once with 100 ml of SDS buffer
and finally with 200 ml of PBS buffer. SDS-stable aggregates
retained on the membrane were detected by immunoblotting
analysis using anti-human AT3Q26 Z46 polyclonal antibody [41].
Membranes were incubated for 60 min at room temperature with
the antibody at 1:5000 dilution in blocking solution. After
incubation in primary antibody, membranes were rinsed thrice
in 0.3% Tween in PBS for 10 min each time, and incubated for
60 min at 25uC in secondary antibody (horseradish peroxidase-
goat anti-rabbit antibodies) at 1.5000 dilution. Immunoreactive
bands were revealed using ECL Western blotting reagent (GE
Healthcare LifeSciences, Little Chalfont, England).
FTIR spectroscopy
For the FTIR study of the AT3 variants, measurements were
performed in attenuated total reflection (ATR) on a single reflection
diamond element(Golden Gate, USA). An aliquotofabout5-10 mlof
the protein solution (in PBS at a concentration of 1 mg/ml) was
deposited on the diamond ATR plate and dried at room temperature
in order to obtain a protein hydrated film. Its ATR/FTIR spectrum
was then measured using the FTS40-A spectrometer (Digilab, USA),
equipped with a nitrogen cooled Mercury Cadmium Telluride
(MCT) detector and carefully purged by dry air to avoid interference
with water vapor under the following conditions: 2 cm
21 spectral
resolution, 20 kHz scan speed, 1000 scan co-additions, triangular
apodization. Second derivatives of the spectra were obtained by the
Savitzky-Golay algorithm (5 points), after an 11 point binomial
smoothing of the measured spectra, using the software Grams/AI
(Thermogalactic, USA). To study the aggregation kinetics, the three
AT3 variants were incubated at 37uC in PBS, and the ATR/FTIR
spectra of their hydrated films were measured at different times. For
the hydrogen/deuterium exchange experiments, two different
procedures were employed: i) the freshly prepared AT3Q55 variant
was resuspended in heavy water and incubated at 37uCf o ru pt o
168 h. Under these conditions, H/D exchange took place during the
protein misfolding and aggregation. In this way, deuterated
aggregates were obtained and measured in ATR/FTIR as described
above; ii) AT3Q55 mature aggregates were obtained after incubation
of the native protein in H2O/PBS at 37uC for 168 h. To remove and
replace H2Ow i t hD 2O, aggregates were subjected to, three cycles of
lyophilization and resuspension in D2O. After each resuspension,
they were incubated at room temperature for 3 h. The final sample
was again resuspended in D2O and incubated at room temperature
for 17 h before ATR/FTIR measurements.
AFM
AT3 was incubated at a 1 mg/ml-concentration in PBS at
37uC. Samples for AFM inspection were prepared at fixed
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procedure, a 10 ml aliquot was withdrawn, incubated on a freshly
cleaved mica substrate for 5 min, then rinsed with Milli-Q water
and dried under mild vacuum. In the second procedure, a 2 ml
aliquot was diluted 400-fold and 10 ml of the diluted solution were
deposited on mica and then dried under mild vacuum. When
imaged by AFM, samples prepared according these two
procedures displayed similar features, only differing in the
aggregate density. To eliminate the non-fibrillar material masking
AT3Q55 fibril morphology at long aggregation times (48 and
72 h), and to recover the insoluble fibrillar fraction, 30 ml aliquots
of AT3Q55 were added to 300 ml of SDS buffer (50 mM Tris-
HCl, pH 8.0, 5% SDS, 10 mM DTT, 100 mM NaCl, 1 mM
EDTA) and boiled at 100uC for 10 min. The sample was then
centrifuged at 150006g for 15 min and the supernatant was
replaced by Milli-Q water; this centrifugation and washing
procedure was repeated three times in total. The pellet was finally
suspended in Milli-Q water. For AFM imaging, the fibril
suspension was diluted 100-fold and 10 ml of the diluted sample
were deposited on mica and then dried under mild vacuum. AFM
images were acquired in tapping mode in air using a Dimension
3100 Scanning Probe Microscope equipped with a ‘G’ scanning
head (maximum scan size 100 mm) and driven by a Nanoscope
IIIa controller, and a Multimode Scanning Probe Microscope
equipped with ‘‘E’’ scanning head (maximum scan size 10 mm)
and driven by a Nanoscope IV controller (Digital Instruments -
Veeco, Santa Barbara, CA). Single beam uncoated silicon
cantilevers (type OMCL-AC160TS, Olympus, Tokyo, Japan)
were used. The drive frequency was between 320 and 340 kHz,
the scan rate was between 0.5 and 2.0 Hz. Aggregate heights were
measured from the height in cross section of the topographic AFM
images; standard errors are reported. Due to the drying procedure
applied, the measured heights reported in the Results are reduced
with respect to fully hydrated conditions. A shrinking factor of 2.2
has been evaluated by comparing the heights of a globular protein
under liquid and in air after drying under vacuum [43].
Supporting Information
Figure S1 FTIR second derivative spectra of AT3
variant aggregates. AT3 variants were incubated at 37uC for
168 h. The spectra of the pelletted aggregates are reported after
normalization at the tyrosine peak.
(TIF)
Figure S2 FTIR absorption spectra of freshly purified
(blue profile) and mature pelleted aggregates (red
profile) of AT3 variants.
(TIF)
Figure S3 FTIR spectra of AT3Q55 aggregates treated
with SDS buffer.
(TIF)
Figure S4 Tapping mode AFM images (height data) of
the truncated variant AT3/182D. The protein was incubated
at 37uC for: (A) 0 h; (B) 24 h; (C) 72 h. Scan size 2 mm, Z range
(A) 10 nm; (B) 20 nm; (C) 15 nm.
(TIF)
Figure S5 Tapping mode AFM images (height data) of
the normal full length variant AT3Q24. The protein was
incubated at 37uC for: (A) 0 h; (B) 24 h; (C) 72 h. Scan size 2 mm,
Z range 20 nm.
(TIF)
Figure S6 Tapping mode AFM image (left, height data;
right, amplitude data) of the expanded variant AT3Q55.
The protein was incubated at 37uC for 48 h. Non fibrillar material
completely covering a fibril bundle is apparent in the middle of the
image. A portion of another bundle is on the left. This
unstructured material can be removed by sample treatment with
SDS, to reveal the fibril morphology (see Fig.6). Scan size 1.9 mm,
Z range 200 nm.
(TIF)
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